Change search
ReferencesLink to record
Permanent link

Direct link
Pharmacological stimulation of GAL1R but not GAL2R attenuates kainic acid-induced neuronal cell death in the rat hippocampus
Stockholm University, Faculty of Science, Department of Neurochemistry.ORCID iD: 0000-0001-9671-0354
Stockholm University, Faculty of Science, Department of Neurochemistry.
Show others and affiliations
2016 (English)In: Neuropeptides, ISSN 0143-4179, E-ISSN 1532-2785, Vol. 58, 83-92 p.Article in journal (Refereed) Published
Abstract [en]

The neuropeptide galanin is widely distributed in the central and peripheral nervous systems and part of a bigger family of bioactive peptides. Galanin exerts its biological activity through three G-protein coupled receptor subtypes, GAL1–3R. Throughout the last 20 years, data has accumulated that galanin can have a neuroprotective effect presumably mediated through the activation of GAL1R and GAL2R. In order to test the pharmaceutical potential of galanin receptor subtype selective ligands to inhibit excitotoxic cell death, the GAL1R selective ligand M617 and the GAL2R selective ligand M1145 were compared to the novel GAL1/2R ligand M1154, in their ability to reduce the excitotoxic effects of intracerebroventricular injected kainate acid in rats.

The peptide ligands were evaluated in vitro for their binding preference in a competitive 125I-galanin receptor subtype binding assay, and G-protein signaling was evaluated using both classical signaling and a label-free real-time technique. Even though there was no significant difference in the time course or severity of the kainic acid induced epileptic behavior in vivo, administration of either M617 or M1154 before kainic acid administration significantly attenuated the neuronal cell death in the hippocampus. Our results indicate the potential therapeutic value of agonists selective for GAL1R in the prevention of neuronal cell death. 

Place, publisher, year, edition, pages
2016. Vol. 58, 83-92 p.
Keyword [en]
Galanin, Galanin receptor subtype selective ligands, GAL1R, GAL2R, Label-free real-time technology, XCELLigence, Excitotoxicity, M1154
National Category
Biochemistry and Molecular Biology
Research subject
Neurochemistry with Molecular Neurobiology
Identifiers
URN: urn:nbn:se:su:diva-125756DOI: 10.1016/j.npep.2015.12.009OAI: oai:DiVA.org:su-125756DiVA: diva2:895125
Funder
Swedish Research CouncilStiftelsen Olle Engkvist ByggmästareHelge Ax:son Johnsons stiftelse
Available from: 2016-01-18 Created: 2016-01-18 Last updated: 2016-09-14Bibliographically approved
In thesis
1. Galanin receptor ligands: Design, synthesis, characterization and biological effects
Open this publication in new window or tab >>Galanin receptor ligands: Design, synthesis, characterization and biological effects
2016 (English)Licentiate thesis, comprehensive summary (Other academic)
Abstract [en]

Galanin is a 29/30 amino acid long bioactive peptide discovered over 30 years ago when C-terminally amidated peptides were isolated from porcine intestines. The name galanin originates from a combination of the first and last amino acids - G from glycine and the rest from alanine. The first 15 amino acids are highly conserved among species which indicates that the N-terminus is important for receptor recognition and subsequent binding. Galanin exerts its effects by binding to three different G-protein coupled receptors, which all differ in regional distribution, the affinity for shortened galanin fragments, as well as the G-protein signaling cascade used. At the time of publication, galanin was found to cause muscle contraction as well as hyperglycemia.  Over the years, galanin has been reported to be involved in a wide variety of biological and pathological functions, for example epilepsy, food intake and depression.

Determining the specific involvement of the three different galanin receptors in several biological and pathological processes is limited by the small amount of galanin receptor selective/specific ligands available as research tools. Furthermore, the fast degradation of peptides limits the administration routes in animal studies.

This thesis aims at developing new galanin receptor-selective ligands to help delineate the involvement of the three different galanin receptors also known as the galaninergic system.

Paper 1 demonstrates that the neuroprotective effects of galanin in a kainic acid induced excitotoxic animal model was mediated through galanin receptor 1. Furthermore, a new robust protocol for evaluating G-protein signaling using a label-free real time impedance technique was presented and compared to two different classical second-messenger assays.

Paper 2 presents a series of systemically active galanin receptor 2 selective ligands subsequently evaluated in two different depression-like animal models.

In conclusion, this thesis presents six new galanin ligands, which can be used to evaluate the galaninergic system as well as to investigate the possible use of peptides as pharmaceuticals.

Place, publisher, year, edition, pages
Stockholm: Department of Neurochemistry, 2016. 60 p.
National Category
Other Chemistry Topics
Research subject
Neurochemistry with Molecular Neurobiology
Identifiers
urn:nbn:se:su:diva-125749 (URN)978-91-7649-338-0 (ISBN)
Presentation
2016-02-08, Heilbronnsalen, C458, Svante Arrheniusv. 16B, Stockholm, 14:00 (English)
Opponent
Supervisors
Available from: 2016-01-18 Created: 2016-01-18 Last updated: 2016-01-18Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Webling, KristinLangel, Ülo
By organisation
Department of Neurochemistry
In the same journal
Neuropeptides
Biochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 18 hits
ReferencesLink to record
Permanent link

Direct link